Calcium Acetate Tablets are phosphate-binding agents used to control high blood phosphate levels in Chronic Kidney Disease (CKD) patients, especially during dialysis. They help reduce dietary phosphate absorption, maintain calcium balance, and prevent complications like renal osteodystrophy. Eskag Pharma offers high-quality formulations with consistent results and export-ready packaging.
Each tablet contains Calcium Acetate 667 mg or 800 mg, delivering approximately 169–200 mg of elemental calcium. Available in film-coated or chewable forms for ease of administration and dietary flexibility in CKD therapy.
If you are interested on Calcium Acetate Tablets, then
It is used as a phosphate binder to bind dietary phosphate in the gut and reduce serum phosphate levels in dialysis patients.
Calcium Acetate Tablets are available in 667 mg and 800 mg strengths, in film-coated or chewable tablet forms to support different patient preferences and dietary needs.
Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the container tightly closed and out of reach of children.
Yes. Eskag Pharma provides contract manufacturing and export supply for Calcium Acetate Tablets, with flexible batch sizes and custom branding options.
Packaging, artwork, and language can be customized as per the regulatory and commercial requirements of different export markets, subject to agreement.
Comprehensive documentation including COA, stability data, and regulatory support dossiers can be provided to partners as part of the manufacturing and export engagement.